Posttreatment FDG‐PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma

Background Metabolic response assessment for oropharyngeal squamous cell carcinoma (OPSCC) aids in identifying locoregional persistence/recurrence (LRR). The Hopkins Criteria are a standardized qualitative response assessment system using posttreatment FDG‐PET/CT. Methods We conducted a retrospectiv...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Head & neck 2022-11, Vol.44 (11), p.2491-2504
Hauptverfasser: Miller, Jacob A., Moradi, Farshad, Sundaram, Vandana, Liang, Rachel, Zhang, Carrie, Nguyen, Ngan Kim, Akhtar, Faisal, Liu, Yuhan, Ren, Yulan, Harandi, Nima, Weng, Yingjie, Pollom, Erqi L., Colevas, Alexander Dimitrios, Divi, Vasu, Holsinger, Floyd Christopher, Beadle, Beth M., Le, Quynh‐Thu, Gensheimer, Michael F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2504
container_issue 11
container_start_page 2491
container_title Head & neck
container_volume 44
creator Miller, Jacob A.
Moradi, Farshad
Sundaram, Vandana
Liang, Rachel
Zhang, Carrie
Nguyen, Ngan Kim
Akhtar, Faisal
Liu, Yuhan
Ren, Yulan
Harandi, Nima
Weng, Yingjie
Pollom, Erqi L.
Colevas, Alexander Dimitrios
Divi, Vasu
Holsinger, Floyd Christopher
Beadle, Beth M.
Le, Quynh‐Thu
Gensheimer, Michael F.
description Background Metabolic response assessment for oropharyngeal squamous cell carcinoma (OPSCC) aids in identifying locoregional persistence/recurrence (LRR). The Hopkins Criteria are a standardized qualitative response assessment system using posttreatment FDG‐PET/CT. Methods We conducted a retrospective cohort study of patients with node‐positive OPSCC treated with definitive (chemo)radiotherapy. We assessed Hopkins Criteria performance for LRR, then developed and validated a competing‐risks model. Results Between 2004 and 2018, 259 patients were included with median follow‐up of 43 months. The Hopkins Criteria sensitivity, specificity, negative predictive value, and accuracy were 68%, 88%, 95%, and 85%. The 36‐month cumulative incidence of LRR was greater with positive scores (45% vs. 5%, HR 12.60, p 
doi_str_mv 10.1002/hed.27160
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2697674826</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2697674826</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3300-8b2e9654ccdd9f7db6c8eb5e81b2d5bb7e38d45ef71973d5caf2ce1ce5ab67c13</originalsourceid><addsrcrecordid>eNp1kc1O3DAUhaOKSgXaRd_AEhtYhPFPYidLNAxMJaSymK4jx75hTJM4XDtUs-sjVOob8iR4OqyQurp38Z1zz9XJsq-MXjJK-WIL9pIrJumH7JjRWuVUFOpovxciF1QVn7KTEB4ppUIW_Dj7e-9DjAg6DjBGcnN9-_L7z_1qs1huyNpPP90YiEEXAZ0mE4J1JpLeG4_w4Pyoe4JgZkQYDRDdJY5Y6NzoonsGgto6H7eAetqRziPx6Ketxt34AEkanmY9-DldgL4nRqNxox_05-xjp_sAX97mafbjZrVZrvO777fflld3uRGC0rxqOdSyLIyxtu6UbaWpoC2hYi23ZdsqEJUtSugUq5WwpdEdN8AMlLqVyjBxmp0ffCf0TzOE2Awu7KPoEVKqhstaSVVUXCb07B366GdM7ydKcS4Zr8q94cWBMuhDQOiaCd2Q3m0Ybfb1NKme5l89iV0c2F-uh93_wWa9uj4oXgEagpZU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2722612851</pqid></control><display><type>article</type><title>Posttreatment FDG‐PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma</title><source>Wiley Online Library</source><creator>Miller, Jacob A. ; Moradi, Farshad ; Sundaram, Vandana ; Liang, Rachel ; Zhang, Carrie ; Nguyen, Ngan Kim ; Akhtar, Faisal ; Liu, Yuhan ; Ren, Yulan ; Harandi, Nima ; Weng, Yingjie ; Pollom, Erqi L. ; Colevas, Alexander Dimitrios ; Divi, Vasu ; Holsinger, Floyd Christopher ; Beadle, Beth M. ; Le, Quynh‐Thu ; Gensheimer, Michael F.</creator><creatorcontrib>Miller, Jacob A. ; Moradi, Farshad ; Sundaram, Vandana ; Liang, Rachel ; Zhang, Carrie ; Nguyen, Ngan Kim ; Akhtar, Faisal ; Liu, Yuhan ; Ren, Yulan ; Harandi, Nima ; Weng, Yingjie ; Pollom, Erqi L. ; Colevas, Alexander Dimitrios ; Divi, Vasu ; Holsinger, Floyd Christopher ; Beadle, Beth M. ; Le, Quynh‐Thu ; Gensheimer, Michael F.</creatorcontrib><description>Background Metabolic response assessment for oropharyngeal squamous cell carcinoma (OPSCC) aids in identifying locoregional persistence/recurrence (LRR). The Hopkins Criteria are a standardized qualitative response assessment system using posttreatment FDG‐PET/CT. Methods We conducted a retrospective cohort study of patients with node‐positive OPSCC treated with definitive (chemo)radiotherapy. We assessed Hopkins Criteria performance for LRR, then developed and validated a competing‐risks model. Results Between 2004 and 2018, 259 patients were included with median follow‐up of 43 months. The Hopkins Criteria sensitivity, specificity, negative predictive value, and accuracy were 68%, 88%, 95%, and 85%. The 36‐month cumulative incidence of LRR was greater with positive scores (45% vs. 5%, HR 12.60, p &lt; 0.001). PET/CTs performed ≤10 weeks after radiotherapy were associated with a four‐fold increase in pathologically negative biopsies/surgeries (36% vs. 9%, p = 0.03). The AUC for LRR was 0.89 using a model integrating the Hopkins score. Conclusions The Hopkins Criteria predict LRR with high accuracy for OPSCC response assessment.</description><identifier>ISSN: 1043-3074</identifier><identifier>EISSN: 1097-0347</identifier><identifier>DOI: 10.1002/hed.27160</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Biopsy ; Head &amp; neck cancer ; Hopkins criteria ; locoregional recurrence ; Metabolic response ; oropharynx cancer ; Patients ; PET/CT ; Radiation therapy ; response assessment ; Squamous cell carcinoma ; Throat cancer</subject><ispartof>Head &amp; neck, 2022-11, Vol.44 (11), p.2491-2504</ispartof><rights>2022 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3300-8b2e9654ccdd9f7db6c8eb5e81b2d5bb7e38d45ef71973d5caf2ce1ce5ab67c13</citedby><cites>FETCH-LOGICAL-c3300-8b2e9654ccdd9f7db6c8eb5e81b2d5bb7e38d45ef71973d5caf2ce1ce5ab67c13</cites><orcidid>0000-0001-5497-2831 ; 0000-0002-8480-5492</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhed.27160$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhed.27160$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids></links><search><creatorcontrib>Miller, Jacob A.</creatorcontrib><creatorcontrib>Moradi, Farshad</creatorcontrib><creatorcontrib>Sundaram, Vandana</creatorcontrib><creatorcontrib>Liang, Rachel</creatorcontrib><creatorcontrib>Zhang, Carrie</creatorcontrib><creatorcontrib>Nguyen, Ngan Kim</creatorcontrib><creatorcontrib>Akhtar, Faisal</creatorcontrib><creatorcontrib>Liu, Yuhan</creatorcontrib><creatorcontrib>Ren, Yulan</creatorcontrib><creatorcontrib>Harandi, Nima</creatorcontrib><creatorcontrib>Weng, Yingjie</creatorcontrib><creatorcontrib>Pollom, Erqi L.</creatorcontrib><creatorcontrib>Colevas, Alexander Dimitrios</creatorcontrib><creatorcontrib>Divi, Vasu</creatorcontrib><creatorcontrib>Holsinger, Floyd Christopher</creatorcontrib><creatorcontrib>Beadle, Beth M.</creatorcontrib><creatorcontrib>Le, Quynh‐Thu</creatorcontrib><creatorcontrib>Gensheimer, Michael F.</creatorcontrib><title>Posttreatment FDG‐PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma</title><title>Head &amp; neck</title><description>Background Metabolic response assessment for oropharyngeal squamous cell carcinoma (OPSCC) aids in identifying locoregional persistence/recurrence (LRR). The Hopkins Criteria are a standardized qualitative response assessment system using posttreatment FDG‐PET/CT. Methods We conducted a retrospective cohort study of patients with node‐positive OPSCC treated with definitive (chemo)radiotherapy. We assessed Hopkins Criteria performance for LRR, then developed and validated a competing‐risks model. Results Between 2004 and 2018, 259 patients were included with median follow‐up of 43 months. The Hopkins Criteria sensitivity, specificity, negative predictive value, and accuracy were 68%, 88%, 95%, and 85%. The 36‐month cumulative incidence of LRR was greater with positive scores (45% vs. 5%, HR 12.60, p &lt; 0.001). PET/CTs performed ≤10 weeks after radiotherapy were associated with a four‐fold increase in pathologically negative biopsies/surgeries (36% vs. 9%, p = 0.03). The AUC for LRR was 0.89 using a model integrating the Hopkins score. Conclusions The Hopkins Criteria predict LRR with high accuracy for OPSCC response assessment.</description><subject>Biopsy</subject><subject>Head &amp; neck cancer</subject><subject>Hopkins criteria</subject><subject>locoregional recurrence</subject><subject>Metabolic response</subject><subject>oropharynx cancer</subject><subject>Patients</subject><subject>PET/CT</subject><subject>Radiation therapy</subject><subject>response assessment</subject><subject>Squamous cell carcinoma</subject><subject>Throat cancer</subject><issn>1043-3074</issn><issn>1097-0347</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kc1O3DAUhaOKSgXaRd_AEhtYhPFPYidLNAxMJaSymK4jx75hTJM4XDtUs-sjVOob8iR4OqyQurp38Z1zz9XJsq-MXjJK-WIL9pIrJumH7JjRWuVUFOpovxciF1QVn7KTEB4ppUIW_Dj7e-9DjAg6DjBGcnN9-_L7z_1qs1huyNpPP90YiEEXAZ0mE4J1JpLeG4_w4Pyoe4JgZkQYDRDdJY5Y6NzoonsGgto6H7eAetqRziPx6Ketxt34AEkanmY9-DldgL4nRqNxox_05-xjp_sAX97mafbjZrVZrvO777fflld3uRGC0rxqOdSyLIyxtu6UbaWpoC2hYi23ZdsqEJUtSugUq5WwpdEdN8AMlLqVyjBxmp0ffCf0TzOE2Awu7KPoEVKqhstaSVVUXCb07B366GdM7ydKcS4Zr8q94cWBMuhDQOiaCd2Q3m0Ybfb1NKme5l89iV0c2F-uh93_wWa9uj4oXgEagpZU</recordid><startdate>202211</startdate><enddate>202211</enddate><creator>Miller, Jacob A.</creator><creator>Moradi, Farshad</creator><creator>Sundaram, Vandana</creator><creator>Liang, Rachel</creator><creator>Zhang, Carrie</creator><creator>Nguyen, Ngan Kim</creator><creator>Akhtar, Faisal</creator><creator>Liu, Yuhan</creator><creator>Ren, Yulan</creator><creator>Harandi, Nima</creator><creator>Weng, Yingjie</creator><creator>Pollom, Erqi L.</creator><creator>Colevas, Alexander Dimitrios</creator><creator>Divi, Vasu</creator><creator>Holsinger, Floyd Christopher</creator><creator>Beadle, Beth M.</creator><creator>Le, Quynh‐Thu</creator><creator>Gensheimer, Michael F.</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5497-2831</orcidid><orcidid>https://orcid.org/0000-0002-8480-5492</orcidid></search><sort><creationdate>202211</creationdate><title>Posttreatment FDG‐PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma</title><author>Miller, Jacob A. ; Moradi, Farshad ; Sundaram, Vandana ; Liang, Rachel ; Zhang, Carrie ; Nguyen, Ngan Kim ; Akhtar, Faisal ; Liu, Yuhan ; Ren, Yulan ; Harandi, Nima ; Weng, Yingjie ; Pollom, Erqi L. ; Colevas, Alexander Dimitrios ; Divi, Vasu ; Holsinger, Floyd Christopher ; Beadle, Beth M. ; Le, Quynh‐Thu ; Gensheimer, Michael F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3300-8b2e9654ccdd9f7db6c8eb5e81b2d5bb7e38d45ef71973d5caf2ce1ce5ab67c13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Biopsy</topic><topic>Head &amp; neck cancer</topic><topic>Hopkins criteria</topic><topic>locoregional recurrence</topic><topic>Metabolic response</topic><topic>oropharynx cancer</topic><topic>Patients</topic><topic>PET/CT</topic><topic>Radiation therapy</topic><topic>response assessment</topic><topic>Squamous cell carcinoma</topic><topic>Throat cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miller, Jacob A.</creatorcontrib><creatorcontrib>Moradi, Farshad</creatorcontrib><creatorcontrib>Sundaram, Vandana</creatorcontrib><creatorcontrib>Liang, Rachel</creatorcontrib><creatorcontrib>Zhang, Carrie</creatorcontrib><creatorcontrib>Nguyen, Ngan Kim</creatorcontrib><creatorcontrib>Akhtar, Faisal</creatorcontrib><creatorcontrib>Liu, Yuhan</creatorcontrib><creatorcontrib>Ren, Yulan</creatorcontrib><creatorcontrib>Harandi, Nima</creatorcontrib><creatorcontrib>Weng, Yingjie</creatorcontrib><creatorcontrib>Pollom, Erqi L.</creatorcontrib><creatorcontrib>Colevas, Alexander Dimitrios</creatorcontrib><creatorcontrib>Divi, Vasu</creatorcontrib><creatorcontrib>Holsinger, Floyd Christopher</creatorcontrib><creatorcontrib>Beadle, Beth M.</creatorcontrib><creatorcontrib>Le, Quynh‐Thu</creatorcontrib><creatorcontrib>Gensheimer, Michael F.</creatorcontrib><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Head &amp; neck</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miller, Jacob A.</au><au>Moradi, Farshad</au><au>Sundaram, Vandana</au><au>Liang, Rachel</au><au>Zhang, Carrie</au><au>Nguyen, Ngan Kim</au><au>Akhtar, Faisal</au><au>Liu, Yuhan</au><au>Ren, Yulan</au><au>Harandi, Nima</au><au>Weng, Yingjie</au><au>Pollom, Erqi L.</au><au>Colevas, Alexander Dimitrios</au><au>Divi, Vasu</au><au>Holsinger, Floyd Christopher</au><au>Beadle, Beth M.</au><au>Le, Quynh‐Thu</au><au>Gensheimer, Michael F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Posttreatment FDG‐PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma</atitle><jtitle>Head &amp; neck</jtitle><date>2022-11</date><risdate>2022</risdate><volume>44</volume><issue>11</issue><spage>2491</spage><epage>2504</epage><pages>2491-2504</pages><issn>1043-3074</issn><eissn>1097-0347</eissn><abstract>Background Metabolic response assessment for oropharyngeal squamous cell carcinoma (OPSCC) aids in identifying locoregional persistence/recurrence (LRR). The Hopkins Criteria are a standardized qualitative response assessment system using posttreatment FDG‐PET/CT. Methods We conducted a retrospective cohort study of patients with node‐positive OPSCC treated with definitive (chemo)radiotherapy. We assessed Hopkins Criteria performance for LRR, then developed and validated a competing‐risks model. Results Between 2004 and 2018, 259 patients were included with median follow‐up of 43 months. The Hopkins Criteria sensitivity, specificity, negative predictive value, and accuracy were 68%, 88%, 95%, and 85%. The 36‐month cumulative incidence of LRR was greater with positive scores (45% vs. 5%, HR 12.60, p &lt; 0.001). PET/CTs performed ≤10 weeks after radiotherapy were associated with a four‐fold increase in pathologically negative biopsies/surgeries (36% vs. 9%, p = 0.03). The AUC for LRR was 0.89 using a model integrating the Hopkins score. Conclusions The Hopkins Criteria predict LRR with high accuracy for OPSCC response assessment.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><doi>10.1002/hed.27160</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0001-5497-2831</orcidid><orcidid>https://orcid.org/0000-0002-8480-5492</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1043-3074
ispartof Head & neck, 2022-11, Vol.44 (11), p.2491-2504
issn 1043-3074
1097-0347
language eng
recordid cdi_proquest_miscellaneous_2697674826
source Wiley Online Library
subjects Biopsy
Head & neck cancer
Hopkins criteria
locoregional recurrence
Metabolic response
oropharynx cancer
Patients
PET/CT
Radiation therapy
response assessment
Squamous cell carcinoma
Throat cancer
title Posttreatment FDG‐PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T16%3A30%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Posttreatment%20FDG%E2%80%90PET/CT%20Hopkins%20criteria%20predict%20locoregional%20recurrence%20after%20definitive%20radiotherapy%20for%20oropharyngeal%20squamous%20cell%20carcinoma&rft.jtitle=Head%20&%20neck&rft.au=Miller,%20Jacob%20A.&rft.date=2022-11&rft.volume=44&rft.issue=11&rft.spage=2491&rft.epage=2504&rft.pages=2491-2504&rft.issn=1043-3074&rft.eissn=1097-0347&rft_id=info:doi/10.1002/hed.27160&rft_dat=%3Cproquest_cross%3E2697674826%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2722612851&rft_id=info:pmid/&rfr_iscdi=true